Margaret A. Liu

Q: What Schools Are Affiliated With Margaret A. Liu

Margaret A. Liu is affiliated with the following schools: Colorado College, Imperial College London, University of Oxford, Massachusetts Institute of Technology, United States Military Academy, University of California, San Francisco, Massachusetts General Hospital, Karolinska Institute

Margaret A. Liu's AcademicInfluence.com Rankings

Margaret A. Liu

Biology

#7368

World Rank

#10281

Historical Rank

Virology

#393

World Rank

#402

Historical Rank

Immunology

#966

World Rank

#990

Historical Rank

biology Degrees

Download Badge

Biology

Margaret A. Liu's Degrees

Bachelors Microbiology University of Oxford

Why Is Margaret A. Liu Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Margaret A. Liu is a physician and researcher studying gene expression, immune responses, and vaccines. From 2015 to 2017, Liu served as president of the International Society of Vaccines. She is currently a professor of microbiology and immunology at the University of California, San Francisco and a foreign adjunct professor at the Karolinska Institute in Stockholm, Sweden. Since June 7, 2017, she has been a director of Ipsen S.A. in France.

(See a Problem?)

Margaret A. Liu's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine (1996) (688)
New Generation Vaccines (1990) (676)
DNA vaccines: an historical perspective and view to the future (2011) (415)
Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus (1995) (325)
DNA Vaccines: Progress and Challenges1 (2005) (321)
Priming of Cytotoxic T Lymphocytes by DNA Vaccines: Requirement for Professional Antigen Presenting Cells and Evidence for Antigen Transfer from Myocytes (1997) (310)
Protective CD4+ and CD8+ T Cells against Influenza Virus Induced by Vaccination with Nucleoprotein DNA (1998) (240)
Immunologic basis of vaccine vectors. (2010) (235)
Serine esterase in cytolytic T lymphocytes (1986) (230)
A Comparison of Plasmid DNA and mRNA as Vaccine Technologies (2019) (225)
Human clinical trials of plasmid DNA vaccines. (2005) (203)
Gene-based vaccines and immunotherapeutics (2004) (189)
Can successful vaccines teach us how to induce efficient protective immune responses? (2005) (187)
Gene-based vaccines: recent technical and clinical advances. (2006) (184)
DNA vaccines: recent developments and future possibilities. (2006) (136)
Infection of Human Dendritic Cells by a Sindbis Virus Replicon Vector Is Determined by a Single Amino Acid Substitution in the E2 Glycoprotein (2000) (127)
Vaccine delivery methods using viral vectors. (2007) (122)
New live mycobacterial vaccines: the Geneva consensus on essential steps towards clinical development. (2005) (116)
Gene Vaccines (2003) (106)
Cytotoxic T Lymphocyte and Helper T Cell Responses following HIV Polynucleotide Vaccination (1995) (60)
Humoral and Cellular Immunities Elicited by HIV-1 DNA Vaccination (1996) (50)
Delivery Systems for Gene-based Vaccines (2000) (47)
DNA vaccines : a new era in vaccinology (1995) (45)
Presentation of an exogenous antigen by major histocompatibility complex class I molecules (1994) (42)
Protective Efficacy of Intramuscular Immunization with Naked DNA (1995) (42)
Development of mRNA Vaccines: Scientific and Regulatory Issues (2021) (42)
Science and society – vaccines: Ethical issues for vaccines and immunization (2002) (40)
Vaccine developments (1998) (40)
Gene-based vaccines: Recent developments. (2010) (35)
Overview of DNA Vaccines (1995) (33)
Conditions for estimation of corpus allatum activity in the blowfly, Phormia regina, in vitro (1988) (30)
DNA Vaccines: Recent Developments and the Future (2014) (29)
The Scientific Future of DNA for Immunization (1997) (28)
Immunization against Viral Proteins with Naked DNA (1995) (24)
Humoral and cellular immunities elicited by DNA vaccines: Application to the human immunodeficiency virus and influenza (1996) (18)
Intracellular Targeting of CEA Results in Th1-Type Antibody Responses Following Intradermal Genetic Vaccination by a Needle-Free Jet Injection Device (2007) (18)
DNA vaccines: recent technological and clinical advances. (2006) (17)
Therapeutic vaccination against HIV (2004) (15)
Transfected human dendritic cells as cancer vaccines (1998) (14)
The Key Role of Nucleic Acid Vaccines for One Health (2021) (13)
Reverse transcriptase-based DNA vaccines against drug-resistant HIV-1 tested in a mouse model. (2004) (12)
Vaccines Against Human Hookworm Disease (2004) (10)
DNA vaccines for HIV/AIDS (2006) (9)
8 – Prospects for Induction of Mucosal Immunity by DNA Vaccines (1996) (7)
Vaccines in the 21st century (1999) (7)
Probing prime substrate binding sites of human dipeptidyl peptidase-IV using competitive substrate approach. (2005) (5)
Vaccination with Polynucleotides: A Novel Means of Generating Immunity (1994) (5)
COVID-19 vaccine delivery: an opportunity to set up systems for the future. (2020) (5)
Minor nef gene alterations after human HIV-DNA immunisation (2004) (4)
Gene-based passive antibody protection from HIV (2012) (4)
Live virus vaccines: Something old, something new, something borrowed... (1998) (4)
A timely update of global COVID-19 vaccine development (2020) (4)
WHO informal consultation on regulatory considerations for evaluation of the quality, safety and efficacy of RNA-based prophylactic vaccines for infectious diseases, 20–22 April 2021 (2022) (3)
New Generation Vaccines, Fourth Edition (2004) (3)
Ethical issues for vaccines and immunization (2018) (3)
Overview Biologicals & Immunologicals Recombinant vaccines: technology and applications (1995) (3)
Path to Success and Future Impact of Nucleic Acid Vaccines: DNA and mRNA (2021) (2)
3.7. Naked DNA Vaccination (1996) (2)
New Generation Vaccines, 3rd Edition (2004) (2)
13 Delivery Systems and Adjuvants for DNA Vaccines (1999) (2)
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019 (2020) (2)
From the wild west to the frontiers of immunology: the journey of a Chinese-American scientist (2019) (1)
An interview with Margaret A Liu: the future of gene-based vaccines and immunotherapies, and other musings (2015) (1)
Development of Vaccines for Ebola and Marburg Viruses: Efficacy and Regulatory Considerations (2009) (1)
Cancer vaccines (2011) (1)
Elements of DNA Vaccine Design (2002) (1)
WHO informal consultation on the guidelines for evaluation of the quality, safety, and efficacy of DNA vaccines, Geneva, Switzerland, December 2019 (2020) (1)
The central role of the antigen-specific receptor complex in triggering cytolytic activity of cytotoxic T lymphocytes (1985) (1)
Colloquium Gene-based vaccines and immunotherapeutics (2004) (1)
Chapter 15. DNA Vaccines Coming of Age (1999) (1)
COVID-19 vaccine delivery: an opportunity to set up systems for the future (2021) (1)
37 – Vaccine Development (2002) (0)
Development and evaluation of new therapeutic interventions for chronic hepatitis C virus infection (2015) (0)
Vaccin polynucleotidique contre le virus de l'herpes (1995) (0)
Polynucleotide vaccine against tbc (1995) (0)
Influenza Virus Challenge Correlation with Protective Immunity Against Frequency Induced by a DNA Vaccine and Dose Dependence of CTL Precursor (1999) (0)
5 Art and Science of DNA Vaccines (1998) (0)
Parallel Gene Expression in vivo (1996) (0)
Abstracts of papers presented at the 1998 Meeting on Gene Therapy, September 23-September 27, 1998 (1998) (0)
Polinucleotide vaccine against tuberculosis. (1995) (0)
Transforming Growth Factor-& Mullerian Inhibiting Substance Fiannily of Growth Regulators (1991) (0)
Response from Ulmer, Donnelly and Liu (1993) (0)
Introduction to special issue: International Society for Vaccines Annual Congress 2016 (2017) (0)
Vaccin polynucleotidique contre la tuberculose (1995) (0)
The immunologist’s grail: Vaccines that generate cellular immunity (1997) (0)
DNA-Modified Virus Ankara and Other Heterologous Prime-Boost Immunization Strategies for Effector T Cell Induction (2004) (0)
Review DNA Vaccines: Recent Developments and Future Possibilities (2006) (0)
Gene-based cancer immunotherapy and vaccines. (2005) (0)
Preface (1995) (0)
DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress (2022) (0)
Synthetic HIV genes gag. (1998) (0)
| New Generation Vaccines | Taylor & Francis Group (2004) (0)
Synthetische hepatitis-c gene (1997) (0)
Gene-based Vaccines (2002) (0)
Vacunas de DNA (2016) (0)
Genetic Engineering of Viruses and Virus Vectors , " organized by Bernard Roizman and (2005) (0)
The nucleic acid formulation (1997) (0)
Rapid Publication Effect of Recombinant Soluble CD4 on Human Peripheral Blood Lymphocyte Responses In Vitro (0)
Part II. Mechanism of DNA Uptake and Antigen Presentation: Fate and Function of Foreign Nucleic Acids Use of Plasmid DNA for Direct Gene Transfer and Immunization. (1995) (0)
Immunogenicity of a tuberculosis DNA vaccine encoding a secreted or a mature form of antigen 85A as compared to vaccination with live M. bovis BCG (1997) (0)

This paper list is powered by the following services:

Other Resources About Margaret A. Liu

en.wikipedia.org

What Schools Are Affiliated With Margaret A. Liu?

Margaret A. Liu is affiliated with the following schools:

Margaret A. Liu's Academic­Influence.com Rankings

Margaret A. Liu's Degrees

Why Is Margaret A. Liu Influential?

Margaret A. Liu's Published Works

Published Works

Other Resources About Margaret A. Liu

What Schools Are Affiliated With Margaret A. Liu?

Margaret A. Liu's AcademicInfluence.com Rankings